# FDA 483 - Vista Lifesciences, Inc. - February 11, 2019

Source: https://www.keypedia.com/records/483/vista-lifesciences-inc/4d1cde3d-7aff-4f75-bfe6-a8b3b4dd6884

> FDA 483 for Vista Lifesciences, Inc. on February 11, 2019. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Vista Lifesciences, Inc.
- Inspection Date: 2019-02-11
- Product Type: drugs
- Office Name: Denver District Office
- Summary: An FDA inspection of Vista Lifesciences, Inc., a manufacturer in Englewood, CO, revealed significant deficiencies in their quality management system. The firm failed to adequately establish corrective and preventive action procedures and did not perform required quality audits. These issues indicate a lack of effective oversight and control over product quality and compliance.

## Related Documents

- [483 - 2025-11-04](https://www.keypedia.com/records/483/vista-lifesciences-inc/d8db1c5d-1948-42ae-ae78-b0685c31c95b)

## Related Officers

- [Investigator](https://www.keypedia.com/people/vicky-l-cruz/282da571-56be-48f4-96c6-d590829b12c2)

Company: https://www.keypedia.com/companies/vista-lifesciences-inc/c3853c8e-2979-4b4a-939d-bdc2a3942176

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face